Back to Agenda
Navigating the New FDA: Insights from Former FDA Chief of Staffs
Session Chair(s)
Elizabeth Lange, MPH, MS
VP & Head of Global Regulatory Science, Policy and Intelligence
XX, United States
The session will feature former FDA Chief of Staffs discussing their contributions to regulatory policies, patient engagement, and innovative technologies, offering insights into the evolving regulatory landscape and helping stakeholders navigate FDA
Learning Objective : Identify key initiatives and challenges described by former FDA Chief of Staffs; Explain how the regulatory landscape is evolving and how these changes may influence future drug approval processes; Discuss FDA organizational dynamics and strategic decision-making factors that shape public health outcomes, helping stakeholders to navigate the new FDA more effectively.
Speaker(s)
Panelist
Kalah Auchincloss, JD, MPH
Canal Row Advisors, United States
Elizabeth Jungman, JD, MPH
Hogan Lovells US LLP, United States
Partner, Global Regulatory
Panelist
Keegan Lenihan
Philip Morris International, United States
Lauren Silvis
Tempus, United States
Senior Vice President, External Affairs
Panelist
Julie Tierney
Leavitt Partners, United States
Principal
Panelist
Susan Winckler, JD, RPH
Reagan-Udall Foundation For the FDA, United States
Chief Executive Officer
Have an account?